Mind Medicine Inc.’s stock jumped 51.5% on Thursday after the biotech company said the Food and Drug Administration has granted breakthrough designation for its MM120 LSD-based treatment for ...

Shares of Mind Medicine Inc. climbed over 2% on Tuesday afternoon, on track to break a two-session losing streak, as Evercore ISI initiated coverage with an ‘Outperform’ rating and a bullish ...

MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy Participants MindBio Therapeutics Tue, May 9, 2023, 5:20 AM 3 ...

MindBio clinical trial published in Peer Reviewed Paper Biological Psychiatry First of 8 significant publications on LSD-Microdosing from a Phase 1 clinical trial Phase 1 Clinical trial produced ...